Mario C. Raviglione MD, FRCP

Mario C. Raviglione has been Director of the Global Tuberculosis Programme at the World Health Organization (WHO) since 2003. He contributed to the development of the DOTS strategy in 1994, set up the global drug-resistance surveillance project and the global TB surveillance & monitoring system, and directed the development of the Stop TB Strategy in 2006 and of the post-2015 global TB Strategy in 2014. He is responsible for setting norms, policies and standards on global TB care and control, coordinating technical support to WHO Member States, monitoring the global situation, and developing innovative interventions through translation of new evidence into policies & practice. He has worked in many countries world-wide, has received international awards for his work on TB, and has served as visiting professor in universities in Italy, Switzerland and the USA. He has published over 350 articles and chapters on the topics of infectious diseases, HIV/AIDS and TB in influential health journals and books, including in the last six editions of the Harrison's Principles of Internal Medicine, and has edited the 3rd and 4th edition (2006, 2009) of the reference book "Tuberculosis - A comprehensive International Approach". He graduated from the University of Turin in Italy, and trained in internal medicine and infectious diseases in New York (where he was Chief Medical Resident at Cabrini's Medical Centre) and Boston, where he was appointed an AIDS Clinical Research Fellow at Beth Israel Hospital, Harvard Medical School.